Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma

Archives of Ophthalmology

Volumn 114, Issue 3, 1996, Pages 299-305

  Dreyer, Evan B ^a,e,g,k   Zurakowski, David ^a   Schumer, Robert A ^f   Podos, Steven M ^f,h,i,j   Lipton, Stuart A ^a,b,c,d,e  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g GLAXOSMITHKLINE   (United States)

^h ALLERGAN INC   (United States)

ⁱ ALCON RESEARCH LTD   (United States)

^j Pharmos Corporation   (United States)

^k MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EXCITATORY AMINO ACID; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTOXIN;

ADULT; AGED; AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLAUCOMA; HUMAN; HUMAN TISSUE; MALE; MONKEY; NERVE CELL LESION; NONHUMAN; OPTIC NERVE LESION; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; VISUAL DISORDER; VITREOUS BODY;

EID: 0029915446     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100130295012     Document Type: Article

References (41)

1. Hiller R, Kahn HA Blindness from glaucoma. Am J Ophthalmol. 1975;80:62-69.
2. Javitt JC, McBean AM, Nicholson GA, Babish JD, Warren JL, Krakauer H Undertreatment of glaucoma among black Americans N Engl J Med. 1991;325 1418-1422.
3. Epstein DL. Glaucoma. Philadelphia, Pa: Lea & Febiger; 1986.
4. Neufeld AH. Protection of the optic nerve in glaucoma. In: Drance SM, van Buskirk EM, Neufeld AH, eds Pharmacology of Glaucoma Baltimore, Md: Williams & Wilkins; 1992:292-300.
5. Schumer RA, Podos SM The nerve of glaucomal Arch Ophthalmol. 1994,112 37-44.
6. Choi DW Glutamate neurotoxicity and diseases of the nervous system Neuron. 1988;1.623-634.
7. Macaione S, Campisi R, Albanese A. Glutamate decarboxylase and gamma-aminobutyrate transaminase in the retina. Boll Soc Ital Biol Sper. 1970,46.785-789
8. Meldrum B, Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci. 1990;11 379-387.
9. Lipton SA, Rosenberg PA Excitatory amino acids as a final common pathway for neurologic disorders N Engl J Med. 1994;330:613-622
10. Lucas DR, Newhouse JP. The toxic effect of sodium L-glutamate on the inner layers of the retina Arch Ophthalmol. 1957,58 193-201.
11. Olney JW. Glutamate-induced retinal degeneration in neonatal mice: electron microscopy of the acutely evolving lesion. J Neuropathol Exp Neurol. 1969;28:455-474.
12. Sisk DR, Kuwabara T. Histologic changes in the inner retina of albino rats following intravitreal injection of monosodium L-glutamate Graefes Arch Clin Exp Ophthalmol 1985,223:250-258
13. Azuma N, Kawamura M, Kohsaka S. Morphological and immunohistochemical studies on degenerative changes of the retina and the optic nerve in neonatal rats injected with monosodium-L-glutamate. Nippon Ganka Gakkai Zasshi. 1989:93:72-79.
14. Sucher NJ, Lei SSZ, Lipton SA Calcium channel antagonists attenuate NMDA receptor-mediated neurotoxicity of retinal ganglion cells in culture. Brain Res. 1991;551:297-302
15. 2- flux in mammalian central neurons. Neuroreport. 1990,1 29-32
16. Sucher NJ, Aizenmann E, Lipton SA. N-Methyl-D-aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cells in vitro. J Neurosci 1991;11 966-971.
17. Siliprandi R, Canella R, Carmignoto G, et al. N-Methyl-D-aspartate-induced neurotoxicity in the adult rat retina Vis Neurosci. 1992;8:567-573.
18. 2+: toxicity is blocked by the N-methyl-D-aspartate antagonist MK-801 Proc Natl Acad Sci USA. 1988,85:6556-6560.
19. Dreyer EB, Pan ZH, Storm S, Lipton SA Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death. Neuroreport. 1994,5:5
20. Mosinger JL, Price MT, Bai HY, Xiao H, Wozniak DF, Olney JW. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Exp Neurol 1991;113:10-17.
21. Hannappel E, Pankow G, Grassl F, Brand K, Naumann GO. Amino acid pattern in human aqueous humor of patients with senile cataract and primary open-angle glaucoma Ophthalmic Res. 1985;17 341-343
22. Schonheyder F, Ehlers N, Hust B Remarks on the aqueous humor/plasma ratios for amino acids and related compounds in patients with various chronic ocular disorders. Acta Ophthalmol (Copenh) 1975,53.627-634.
23. Durham DG Distribution of free amino acids in human intraocular fluids. Trans Am Ophthalmol Soc. 1970;68:462-500.
24. Durham DG, Dickinson JC, Hamilton PB. Ion-exchange chromatography of free amino acids in human intraocular fluids Clin Chem. 1971;17:285-289.
25. Welge-Lüssen LL, Oppermann W Amino acid determination in the aqueous humor and vitreous body of single eyes. Graefes Arch Clin Exp Ophthalmol. 1969,177.346-354.
26. Shingleton BJ, Anderson LS, Berson FG, Cantor L, Lee DA Glaucoma. San Francisco, Calif: American Academy of Ophthalmology; 1993 42
27. Katz J, Tielsch JM, Quigley HA, Sommer A. Automated perimetry detects visual field loss before manual Goldmann perimetry. Ophthalmology. 1995,102.21-26.
28. Belfort R, Nussenblatt RB. Surgical approaches to uveitis Int Ophthalmol Clin. 1990,30:314-317
29. Lee PY, Podos SM, Howard WJ, Severin CH, Rose AD, Siegel MJ. Pharmacological testing in the laser-induced monkey glaucoma model Curr Eye Res. 1985,4:775-781.
30. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron. 1991;7:111.
31. Hochberg Y, Tamhane AC. Multiple Comparison Procedures New York, NY: John Wiley & Sons Inc; 1987.
32. SAS/STAT User's Guide v6. 4th ed. Cary, NC: SAS Institute: 1989
33. Rosenberg P, Amin S, Leitner M Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture J Neurosci. 1992;12:56-61.
34. Choi DW, Maulucci-Gedde MA, Kriegstein AR Glutamate neurotoxicity in cortical cell culture J Neurosci. 1987;7:357-368.
35. Patneau DK Mayer ML Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors J Neurosci. 1990,10:2385-2399
36. Samy CN, Lui CJ, Kaiser PK, Lipton SA, Dreyer EB. Toxicity of chronic glutamate administration to the retina Invest Ophthalmol Vis Sci. 1994;35(suppl):497
37. Fechtner RD, Weinreb RN. Mechanisms of optic nerve damage in primary open angle glaucoma Surv Ophthalmol 1994,39:23-42
38. Faden AI, Demediuk P Panter SS, Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury Science 1989;244.798-800
39. Benveniste H, Drejer J, Schousboe A, Diemer NH Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984;43:1369-1374.
40. Svenneby G, Torgner IA Localization and function of glutamine synthetase and glutaminase Biochem Soc Trans 1987;15 213-215
41. Lipton SA. Prospects for clinically tolerated NMDA antagonists Trends Neurosci. 1993;16:527-532